CClinicalTrials.gg
CompletedNCT05505851SCSCRLCSUpdated Dec 15, 2025

Sequential Core Stability Corrective Exercise Approach in Lower Crossed Syndrome

An interventional study of Control and Sequential Core Stability Corrective Exercise Approach in Low Back Pain, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-15.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 28 Years
Sex
All
01

Study summary

The objective of the study will be to determine the effects of Sequential Core Stability Corrective Exercise Approach for Alignment and Muscle Function in Lower Crossed Syndrome.

Read the detailed description

Lower Crossed Syndrome is one of common postural disorder which occurs due to the muscular imbalance. It refers to specific altered muscle activation and movement patterns along with some postural deviations. Alterations in muscle activation include overactivity of hip flexors and lower back muscles paired underactivity of abdominals and gluteus muscle. This pattern of imbalance creates dysfunction. Postural correction exercise with inner and outer core muscles are necessary. There are different traditional structural approach, functional approach and biomechanics and are presumed to lead to adjustments in the length and strength of local muscles while ignoring other related malalignments and core stability. The objective of the study will be to determine the effects of Sequential Core Stability Corrective Exercise Approach for Alignment and Muscle Function in Lower Crossed Syndrome.

It will be a randomized controlled trial. Sample size will be collected after running the pilot study. The participants will be recruited through convenient sampling technique and then allocated randomly to Groups. Outcome measures will be alignment and muscle function. Pre and post reading and after one month follow-up will be recorded. Data will be analyzed using statistical package for social sciences software version 25. After assessing normality of data by Shapiro-Wilk test, it will be decided either parametric or nonparametric test will be use within a group or between two groups.

Keywords: Alignment, Core Stability, Diaphragm, Muscular Imbalance, Muscle thickness Pelvic floor.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Alignment
  • Core Stability
  • Diaphragm
  • Pelvic floor
  • Dysfunction
03

In context

Low Back Pain

2,818 studies on the registry are indexed under Low Back Pain; 482 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 2,268 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 28 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

    • Age group between 18 to 28 years

      • No current incidence of low back pain or past history of low back dysfunction
      • Kendall double leg lowering test: Abdominal muscle weakness to the extent of not being able to maintain posterior pelvic tilt during a double leg lowering test in supine position.
      • Diagnosed with lower cross syndrome through assessment criteria of Janda muscle testing and assessment

Exclusion criteria

Exclusion Criteria:

    • Having any history of low back pain, spinal trauma,

      • Joint dysfunction in past 3 months
      • Congenital deformities at hip or lumbar region,
      • Recent fracture to related joints in past 6 months
      • Any family history of cardiopulmonary disease
      • Any disease or urogenital tract
      • Participants having BMI above 30.
      • Recent history of hepatitis or Fatty liver or
      • Any athlete having high physical activity.
      • History of abdominal, hip or lumbar surgeries in past 3 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    A: Control

    Corrective Exercises: Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge.

    Other: Control

  • Experimental
    B: Sequential Core Stability Corrective Exercise Approach

    Sequential Core Stability Corrective Exercise Approach 1. Corrective Exercises 2. Diaphragm Training Program 3. Pelvic floor Muscle training 4. Core Stability exercises

    Other: Sequential Core Stability Corrective Exercise Approach

Interventions

  • OtherControl

    Corrective Exercises: Hip Flexor Stretch, Thoracolumbar Extensor Stretch, Abdominal Curl, and Glute Bridge.

  • OtherSequential Core Stability Corrective Exercise Approach

    Sequential Core Stability Corrective Exercise Approach 1. Corrective Exercises 2. Diaphragm Training Program 3. Pelvic floor Muscle training 4. Core Stability exercises 1. Beginning 2. Progressing 3. Advanced

06

What researchers measure

Primary outcomes

  1. Photometry for Pelvic Tilt

    Angle of Pelvic tilt will be measured Through a Reliable and validated camera.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  2. Photometry for Chest Expansion

    Angle of Chest expansion will be measured at Nipple line, Xiphoid level and at waist level, Through a Reliable and validated camera.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  3. Photometry for Cervicothoracic level

    Angle of C7-T1 will be measured Through a Reliable and validated camera.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  4. Photometry for Lumber flexion

    Angle of Lumber curve will be measured Through a Reliable and validated camera.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  5. Diaphragmatic excursion

    To assess the diaphragmatic motion by M-mode US a 2.5-5 megahertz (MHz) phase array will be used.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  6. Levator ani Excursion

    To assess the pelvic floor motion by M-mode US a 2.5-5 megahertz (MHz) array will be used.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  7. Diaphragmatic thickness and thickening

    diaphragmatic thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  8. Levator ani thickness and thickening

    Levator ani thicknesses and thickening will be assessed by B-mode ultrasonography during various respiratory maneuvers

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  9. Core stability

    It will be measured by Pressure biofeedback unit for the transverse abdomens.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

Secondary outcomes

  1. Forced Vital Capacity (FVC)

    Pulmonary function test through spirometer, It will be measured by digital spirometer.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  2. Forced Expiratory Volume per second FEV1

    Pulmonary function test through spirometer, It will be measured by digital spirometer.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

  3. Ratio of FEV1/ FVC

    Pulmonary function test through spirometer, It will be measured by digital spirometer.

    Time frame: Pre (0th week), Post (6th week), (12th week) Follow-up

07

Study locations

1 site
  • Al-khumeini Trust Hospital
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05505851
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Aug 18, 2022
Start date
Feb 10, 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Dec 15, 2025

Study contacts

Muhammad Kashif, PhD
study chair · Riphah International University
Wajeeha Zia, PhD*
principal investigator · Riphah International University , QIE, Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion